Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Using index funds to manage risk emphasizes broad diversification and low costs. These funds help smooth returns and reduce exposure to idiosyncratic losses.
27,240 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A high pre-tax withdrawal can push Social Security into higher taxation, prolonging Medicare costs and altering retir...
A former Meta public policy director alleges the company spied on her for more than a year to suppress discussion of ...
A mid-year luxury market report shows AI-generated fortunes fueling a luxury buyers shift wealth, driving demand for ...
Broadcom’s surge in AI-driven sales dwarfs Marvell’s growth, setting a clear benchmark for the AI boom. The contrast ...
Tesla stock has rebounded in recent sessions, creating a balanced risk-reward outlook as markets await the Q2 deliver...
Imagine the next 10 years of your portfolio. This piece explains why Costco's shine may not translate into a top inve...
Rocket Lab faces a watershed moment as it logs another quarter of rising revenue and a multi-billion backlog while we...
Borrowers with a 600 credit score face tighter lending, but flexible programs from a handful of lenders are expanding...
Sen. Mitch McConnell disclosed that a fall caused his hospitalization and that he is in rehab, ending weeks of frenzi...
SpaceX and Amazon share a blueprint for infrastructure growth, but their earnings paths diverge, forcing investors to...
Meta Platforms appears poised for a potential move toward $700 as earnings beat and AI-driven monetization clash with...